Trusted medical search and resources

Evidence-first results

4Medical is a specialist search engine built for clinicians, researchers, patients, and healthcare buyers. It blends multiple indexes, curated content, and AI tools to make medical searches faster and more reliable. Use 4Medical to find clinical guidelines, peer-reviewed research, product specifications, local providers, and up-to-date news with filters for evidence type and source trustworthiness. Part of the 4SEARCH network of topic specific search engines.

Latest

New Study Shows Combination Therapy Beats Breast Cancer Resistance

New Study Shows Combination Therapy Beats Breast Cancer Resistance Health & LifestyleNewsNov 11, 2026142Listen to article (english) https://megadoctornews.com/wp-content/uploads/speaker/post-104829.mp3?cb=1794424777.mp3Translate to Spanish or other 102 languages! A combination approach successfully overcame treatment resistance and led to durable responses in preclinical models of advanced breast cancer, according to researchers at The University of…

901 words4 outlets
More in Cancer

Even Casual Pot Use Tied to Stroke Risk Surge

Health Even Casual Pot Use Tied to Stroke Risk Surge Jessica Williams November 11, 2026 6 min read New research is adding pressure to the debate over cannabis and heart health, with a large U.S. analysis linking marijuana use to higher odds of cardiovascular disease, especially stroke. The study, presented…

754 words2 outlets
More in Heart Disease

Congo's Ebola outbreak tops 11,000 cases as disease keeps spreading

November 11, 2026e-Paper AccounteBooks Subscribe SearchLive Now News SECTION News India World States Cities TOPICS Israel-US strikes on Iran Delimitation Ground Zero Spotlight NEWSLETTER The View From India Looking at World Affairs from the Indian perspective. SEE ALL NEWSLETTERS States Cities Entertainment SECTION Entertainment Art Dance Movies Music Reviews Theatre…

725 words33 outlets
More in Outbreaks & Emerging Diseases

Johnson & Johnson Announces CAPLYTA (lumateperone) Shows Significant and Rapid Improvement in Bipolar Mania in Second Pivotal Phase 3 Study

Johnson & Johnson Announces CAPLYTA (lumateperone) Shows Significant and Rapid Improvement in Bipolar Mania in Second Pivotal Phase 3 Study Updated Tue, November 10, 2026 at 1:04 PM UTCCAPLYTA improved manic symptoms versus placebo as early as Day 3, with improvement sustained through Week 3 and a safety and tolerability…

1,621 words5 outlets
More in Mental Health